Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bulent Cetin

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Current Problems in Cancer|August 15, 2018
Current uses of check inhibitors in the fight against advanced and/or metastatic lung cancer: will immunotherapy overcome chemotherapy?Bulent Cetin, İrem Bilgetekin, Ahmet Ozet
Future Oncology (London, England)|February 9, 2022
CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancerBulent Cetin, Chiara A Wabl, Ozge Gumusay
Critical Reviews in Oncology/Hematology|October 15, 2020
The DNA damaging revolutionBulent Cetin, Chiara A Wabl, Ozge Gumusay
Future Oncology (London, England)|January 18, 2023
Should one use the combination of abiraterone and poly(ADP-ribose) polymerase inhibitors as first-line therapy for all patients with metastatic castration-resistant prostate cancer?Bulent Cetin, Chiara A Wabl, Ozge Gumusay
Current Treatment Options in Oncology|March 22, 2022
Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management : Optimal Management for Renal Cell Cancer PatientsBulent Cetin, Chiara A Wabl, Ozge Gumusay
Immunotherapy|June 9, 2023
Advancing immunotherapy in gastroesophageal cancer through rational combinations and biomarkersBulent Cetin, Chiara A Wabl, Ozge Gumusay
Urologia Internationalis|October 26, 2021
Optimal Treatment for Patients with Oligometastatic Prostate CancerBulent Cetin, Chiara A Wabl, Ozge Gumusay
Indian Journal of Surgical Oncology|December 13, 2018
Managing Synchronous Liver Metastases in Colorectal CancerBulent Cetin, Irem Bilgetekin, Mustafa Cengiz, et al.
Journal of Gastrointestinal Cancer|February 15, 2016
Advances of Molecular Targeted Therapy in Gastric CancerBulent Cetin, Ozge Gumusay, Mustafa Cengiz, et al.
Current Treatment Options in Oncology|April 18, 2026
Beyond CDK4/6 Inhibition: Current Strategies in Hormone Receptor-Positive Metastatic Breast CancerBulent Cetin, Dilek Erdem, Irem Karaman, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Current Problems in Cancer|August 15, 2018
Current uses of check inhibitors in the fight against advanced and/or metastatic lung cancer: will immunotherapy overcome chemotherapy?Bulent Cetin, İrem Bilgetekin, Ahmet Ozet
Future Oncology (London, England)|February 9, 2022
CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancerBulent Cetin, Chiara A Wabl, Ozge Gumusay
Critical Reviews in Oncology/Hematology|October 15, 2020
The DNA damaging revolutionBulent Cetin, Chiara A Wabl, Ozge Gumusay
Future Oncology (London, England)|January 18, 2023
Should one use the combination of abiraterone and poly(ADP-ribose) polymerase inhibitors as first-line therapy for all patients with metastatic castration-resistant prostate cancer?Bulent Cetin, Chiara A Wabl, Ozge Gumusay
Current Treatment Options in Oncology|March 22, 2022
Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management : Optimal Management for Renal Cell Cancer PatientsBulent Cetin, Chiara A Wabl, Ozge Gumusay
Immunotherapy|June 9, 2023
Advancing immunotherapy in gastroesophageal cancer through rational combinations and biomarkersBulent Cetin, Chiara A Wabl, Ozge Gumusay
Urologia Internationalis|October 26, 2021
Optimal Treatment for Patients with Oligometastatic Prostate CancerBulent Cetin, Chiara A Wabl, Ozge Gumusay
Indian Journal of Surgical Oncology|December 13, 2018
Managing Synchronous Liver Metastases in Colorectal CancerBulent Cetin, Irem Bilgetekin, Mustafa Cengiz, et al.
Journal of Gastrointestinal Cancer|February 15, 2016
Advances of Molecular Targeted Therapy in Gastric CancerBulent Cetin, Ozge Gumusay, Mustafa Cengiz, et al.
Current Treatment Options in Oncology|April 18, 2026
Beyond CDK4/6 Inhibition: Current Strategies in Hormone Receptor-Positive Metastatic Breast CancerBulent Cetin, Dilek Erdem, Irem Karaman, et al.
Pageof 8